Patricia Martin-Romano Julien Adam Jean-Yves Scoazec Sébastien Gouy Antonin Levy Capucine Baldini Stéphane Champiat Jean-Charles Soria Christophe Massard Aurélien Marabelle Eric Deutsch Antoine Hollebecque
10.3389/fimmu.2021.745146
Front Immunol
2021 Nov 4;12:745146.
anal squamous cell carcinoma immune microenvironment immunotherapy radiation therapy tumor response
CC BY
https://pubmed.ncbi.nlm.nih.gov/34804027/
Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents, Immunological / therapeutic use Anus Neoplasms / therapy Carcinoma, Squamous Cell / therapy Radiotherapy / adverse effects Tumor Microenvironment / radiation effects
Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents, Immunological / therapeutic use Anus Neoplasms / therapy Carcinoma, Squamous Cell / therapy Radiotherapy / adverse effects Tumor Microenvironment / radiation effects Case Reports Antineoplastic Combined Chemotherapy Protocols / therapeutic use Anus Neoplasms / pathology Carcinoma, Squamous Cell / pathology Chemoradiotherapy / methods Female Humans Immunotherapy / methods Middle Aged Neoplasm Recurrence, Local / drug therapy Neoplasm Recurrence, Local / pathology Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological pembrolizumab
PMC8600981
34804027
Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
2021